The expanding network of redox signaling: New observations, complexities, and perspectives

Journal of Clinical Investigation

Volumn 111, Issue 5, 2003, Pages 571-574

  Soberman, Roy J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CATALASE; CYSTEINE; DNA; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; HYPOXIA INDUCIBLE FACTOR 1; LIGASE; LIPID; LIPOXYGENASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE; NITRIC OXIDE SYNTHASE; OXIDOREDUCTASE; OXYGEN; OXYGEN RADICAL; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN; PROTEIN DISULFIDE ISOMERASE; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; SUPEROXIDE DISMUTASE; THIOREDOXIN; THROMBOXANE; UNINDEXED DRUG; XENOBIOTIC AGENT;

AEROBIC METABOLISM; GENE EXPRESSION; HUMAN; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; OXYGEN TENSION; PRIORITY JOURNAL; REVIEW;

ANIMALS; APOPTOSIS INDUCING FACTOR; CYSTEINE; EICOSANOIDS; FLAVOPROTEINS; HUMANS; MEMBRANE PROTEINS; NAD; OXIDATION-REDUCTION; OXYGEN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0037371945     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200318099     Document Type: Review

References (51)

1. Baehner, R.L., and Karnovsky, M.L. 1968. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science. 162:1277-1279.
2. Baehner, R.L., Gilman, N., and Karnovsky, M.L. 1970. Respiration and glucose oxidation in human and guinea pig leukocytes: comparative studies. J. Clin. Invest. 49:692-700.
3. Baehner, R.L., Nathan, D.G., and Karnovsky, M.L. 1970. Correction of metabolic deficiencies in the leukocytes of patients with chronic granulomatous disease. J. Clin. Invest. 49:865-870.
4. 2, and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell. 107:1-3.
5. Semenza, G.L. 1999. Perspectives on oxygen sensing. Cell. 98:281-284.
6. Semenza, G.L. 2000. HIF-1 and human disease: one highly involved factor. Genes Dev. 14:1983-1991.
7. Bruick, R.K., and McKnight, S.L. 2001. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 294:1337-1340.
8. Min, J.-H., et al. 2002. Structure of an HIF-1-pVHL complex: hydroxyproline recognition in signaling. Science. 296:1886-1889.
9. 2 sensing. Science. 292:464-468.
10. Lando, D., Peet, D.J., Whelan, D.A., Gorman, J.J., and Whitelaw, M.L. 2002. Asparagine hydroxylation of the HIF transactivation domain: a hypoxic switch. Science. 295:858-861.
11. Safran, M., and Kaelin, W.G. 2003. HIF hydroxylation and the mammalian oxygen-sensing pathway. J. Clin. Invest. In press.
12. Rutter, J., Reick, M., Leeju, C., Wu, L.C., and McKnight, S.L. 2001. Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors. Science. 293:510-514.
13. Reick, M., Garcia, J.A., Dudley, C., and McKnight, S.L. 2001. NPAS2: an analog of clock operative in the mammalian forebrain. Science. 293:506-509.
14. Zhang, Q., Piston, D.W., and Goodman, R.H. 2001. Regulation of corepressor function by nuclear NADH. Science. 295:1895-1897.
15. Kim, S.O., et al. 2002. OxyR: a molecular code for redox-related signaling. Cell. 109:383-396.
16. Stamler, J.S., Lamas, L., Ferric, C., and Fang, F.C. 2001. Nitrosylation: the prototypic redox-based signaling mechanism. Cell. 106:675-683.
17. Smith, W.L., and Lands, W.E. 1972. Oxygenation of polyunsaturated fatty acids during prostaglandin biosynthesis by sheep vesicular gland. Biochemistry. 11:3276-3285.
18. Smith, W.L., and Lands, W.E. 1972. Oxygenation of unsaturated fatty acids by soybean lipoxygenase. J. Biol. Chem. 247:1038-1047.
19. Smith, W.L., Garavito, R.M., and DeWitt, D.L. 1996. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 271:33157-33160.
20. FitzGerald, G.A., and Loll, P. 2001. COX in a crystal ball: current status and future promise of prostaglandin research. J. Clin. Invest. 107:1335-1338.
21. Brash, A.R. 2001. Arachidonic acid as a bioactive molecule. J. Clin. Invest. 107:1339-1345.
22. Fitzpatrick, F.A., and Soberman, R.J. 2001. Regulated formation of eicosanoids. J Clin. Invest. 107:1347-1351.
23. Serhan, C.N., and Oliw, E. 2001. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J. Clin. Invest. 107:1481-1489.
24. Smith, W.L., and Langenbach, R. 2001. Why there are two cyclooxygenase isozymes. J. Clin. Invest. 107:1491-1495.
25. Patrono, C., Patrignani, P., and García Rodríguez, L.A. 2001. Cyclooxygenase-selective inhibition of prostanoid formation: transducing biochemical selectivity into clinical read-outs. J. Clin. Invest. 108:7-13. doi: 10.1172/JCI200113418.
26. Tilley, S.L., Coffman, T.M., and Koller, B.H. 2001. Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 108:15-23. doi: 10.1172/JCI200113416.
27. Narumiya, S., and FitzGerald, G.A. 2001. Genetic and pharmacological analysis of prostanoid receptor function. J. Clin. Invest. 108:25-30. doi: 10.1172/JCI200113455.
28. Soberman, R.J., and Christmas, P. 2003. The organization and consequences of eicosanoid signaling. J. Clin. Invest. In press.
29. Lipton, S.A., and Bossy-Wetzel, E. 2002. Dueling activities of AIF in cell death versus survival: DNA binding and redox activity Cell. 111:147-150.
30. Klein, J.A., et al. 2002. The harlequin mouse mutation downregulates apoptosis-inducing factor. Nature. 419:367-374.
31. Klein, J., and Ackerman, S.L. 2003. Oxidative stress, cell cycle, and neurodegeneration. J. Clin. Invest. In press.
32. +-regulated dehydrogenase. Mol. Cell. 10:857-869.
33. Marnett, L.J., Riggins, J.N., and West, J.D. 2003. Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest. 111:583-593. doi: 10.1172/JCI200318002.
34. Moos, P.J., Edes, K., and Fitzpatrick, F.A. 2000. Inactivation of wild-type p53 tumor suppressor by electrophilic prostaglandins. Proc Natl. Acad. Sci. U. S. A. 97:9215-9220.
35. Hildeman, D.A., Mitchell, T., Kappler, J., and Marrack, P. 2003. T cell apopotosis and reactive oxygen species. J. Clin. Invest. 111:576-581. doi: 10.1172/JCI200318007.
36. Nathan, C. 2003. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J. Clin. Invest. In press.
37. Rhee, S.G., Bae, Y.S., Lee, S.-R., and Kwon, J. 2000. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci. STKE. October 10, PE1.
38. 2 for platelet-derived growth factor signal transduction. Science. 270:296-299.
39. May, J.M., and de Haen, C. 1979. Insulin-stimulated intracellular hydrogen peroxide production in rat epididymal far cells. J. Biol. Chem. 254:2214-2220.
40. 4 stimulates rac-ERK cascade to generate reactive oxygen species that mediates chemotaxis. J. Biol. Chem. 277:8572-8578.
41. Denu, J.M., and Dixon, J.E. 1998. Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Curr. Opin. Chem. Biol. 2:633-641.
42. Lee, S.R., Kwon, K.S., Kim, S.R., and Rhee, S.G. 1998. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:15366-15372.
43. Denu, J.M., and Tanner, K.G. 1998. Specific and reversible inactivation of protein tyrosine phosphatases by hydrogen peroxide: evidence for a sulfenic acid intermediate and implications for redox regulation. Biochemistry. 37:5633-5642.
44. Fetrow, J.S., Siew, N., and Skolnick, J. 1999. Structure-based functional motifidentifies a potential disulfide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily. FASEB J. 13:1866-1874.
45. Saitoh, M., et al. 1998. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK)1. EMBO J. 17:2596-2600.
46. Liu, H., Nishiroh, H., Ichijo, H., and Kyriakis, J.M. 2000. Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell. Biol. 20:2198-2208.
47. Arunachalam, B., Phan, U.T., Geuze, H.J., and Cresswell, P. 2000. Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc. Natl. Acad. Sci. U. S. A. 97:745-750.
48. Phan, U.T., Arunachalam, B., and Cresswell, P. 2000. Gamma-interferon-inducible lysosomal thiol reductase (GILT): maturation, activity and mechanism of action. J. Biol. Chem. 275:25907-25914.
49. Lander, H.M., et al. 1996. Redox regulation of cell signalling. Nature. 381:380-381.
50. Cumming, R.C., et al. 2001. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat. Med. 7:814-820.
51. Jack, P-M. 2003. Drug design based on oxidation-reduction. J. Clin. Invest. In press.